Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
Sven A. Lang(Essen University Hospital), Oliver Stoeltzing(The University of Texas MD Anderson Cancer Center), Edward K. Geissler(University Hospital Regensburg), Gudrun E. Koehl, Hans J. Schlitt(University Hospital Regensburg), Andreas Gäumann(University of Regensburg), Ulrike Seidel(University of Regensburg), Dagmar Klein(University of Regensburg), Frauke Bataille(University of Regensburg), Ferdinand Hofstaedter(University of Regensburg), Ulrich Bolder(University of Regensburg), Lee M. Ellis(The University of Texas MD Anderson Cancer Center)
Cited by 167
Related Papers
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
|Annals of Surgery|2012|1.3k
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
|Frontiers in Immunology|2012|820